ALX Oncology Holdings Inc
ALXO · NASDAQ
ALX Oncology Holdings Inc. operates as a clinical stage immuno-oncology company. The Company focuses on helping patients fight cancer by developing therapies that bridge the innate and adaptive immune system. ALX Oncology Holdings serves patients in the State of California.
Market Data
Price
$2.05
-0.08 (-3.76%)
Market Cap$279M
P/E Ratio—
EPS$—
52W High$2.66
52W Low$0.40
Beta0.56
Data from Finnhub · Updated Mar 11, 2026